Skip to main content

Table 4 Inter-dataset agreement for ATC level 2 medications (Cohen’s kappa)

From: Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment

 

EDR versus Clinician Record

EDR versus Self-Report

Clinician Record versus Self-Report

 

kappa

95% CI

Strength

PABAK

95% CI

kappa

95% CI

Strength

PABAK

95% CI

kappa

95% CI

Strength

PABAK

95% CI

none

0.33

0.27; 0.39

slight

0.33

0.27; 0.39

0.20

0.15; 0.24

slight

0.25

0.19; 0.31

0.09

0.04; 0.14

slight

0.10

0.04; 0.58

none + TCAMa

     

0.03

-0.01; 0.08

slight

0.11

0.04; 0.17

0.06

-0.01; 0.14

slight

0.58

0.53; 0.63

A02

none PER

   

0.13

0.06; 0.20

slight

0.63

0.59; 0.68

     

A03

-0.00

0.30;-0.01

poor

0.94

0.92;0.96

-0.01

-0.02;-.00

poor

0.93

0.91;0.96

-0.00

-0.00; 0.00

poor

0.99

0.98;1.0

A06

-0.01

-0.02;-0.01

poor

0.95

0.93; 0.97

0.13

-0.05;0.30

slight

0.95

0.93;0.97

-0.01

-0.02;-0.01

poor

0.94

0.92;0.96

A07

0.16

-0.1;0.45

slight

0.98

0.97;0.99

0.37

0.11; 0.64

fair

0.97

0.96;0.99

0.15

-0.11;0.42

slight

0.98

0.96; 0.99

A10

0.26

-0.03; 0.56

fair

0.98

0.96;0.99

0.47

0.17; 0.76

moderate

0.98

0.97; 0.99

-0.00

-0.01; -0.00

poor

0.99

0.98; 1.00

A11

0.02

-0.01;0.04

slight

0.63

0.59; 0.68

0.03

-0.03;0.08

slight

0.55

0.50; 0.60

-0.00

-0.01; 0.00

poor

0.85

0.82; 0.88

A12

-0.00

-0.00;-0.00

poor

0.99

0.98; 1.0

-0.00

-0.01;-0.00

poor

0.97

0.96; 0.99

-0.00

-0.01;0.00

poor

0.98

0.96; 0.99

B01

-0.00

-0.00;-0.00

poor

1.00

0.99; 1.00

none self-report

        

B03

0.03

0.01; 0.05

slight

-0.40

-0.46; -0.35

0.00

-0.03; 0.03

poor

-0.36

-0.42; -0.30

0.02

-0.04; 0.08

slight

0.39

0.34; 0.45

B05

PHDC only

             

C01

PHDC only

             

C02

0.09

-0.08; 0.26

slight

0.96

0.94; 0.98

0.33

0.09; 0.57

fair

0.97

0.95; 0.98

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

C03

0.33

0.08; 0.57

fair

0.97

0.95; 0.98

0.16

-0.5; 0.36

slight

0.96

0.94; 0.98

0.24

-0.04; 0.53

fair

0.97

0.96; 0.99

C07

PHDC only

             

C08

-0.01

-0.01; -0.00

poor

0.97

0.96; 0.99

0.22

-0.14; 0.58

fair

0.99

0.97; 1.00

-0.00

-0.00; 0.00

poor

0.99

0.97; 1.00

C09

0.44

0.04; 0.85

moderate

0.99

0.98; 1.00

0.25

-0.15; 0.65

fair

0.99

0.98; 1.00

0.40

-0.15; 0.94

fair

0.99

0.99; 1.00

C10

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

0.33

-0.15; 0.82

fair

0.99

0.98; 1.00

D01

self-report only

             

D02

0.09

-0.05; 0.22

slight

0.93

0.90; 0.95

0.17

0.03; 0.30

slight

0.90

0.87; 0.92

-0.01

-0.01; 0.00

poor

0.94

0.92; 0.96

D04

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

-0.00

-0.00; 0.00

poor

0.98

0.97; 0.99

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

D06

self-report only

             

D07

0.20

-0.04; 0.43

slight

0.97

0.95; 0.98

0.13

-0.05; 0.31

slight

0.95

0.93; 0.97

-0.00

-0.01; 0.00

poor

0.98

0.96; 0.99

D08

-0.00

-0.00; 0.00

poor

  

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

-0.00

-0.00; 0.00

poor

  

G01

0.03

-0.05; 0.10

slight

0.90

0.87; 0.92

0.11

0.01; 0.21

slight

0.84

0.81; 0.87

0.06

-0.03; 0.16

slight

0.90

0.87; 0.93

G02

self-report only

             

G03

none PER

   

-0.01

-0.02; -0.01

poor

0.95

0.94; 0.97

     

G04

-0.01

-0.01; -0.00

poor

0.98

0.96; 0.99

0.09

-0.10; 0.27

slight

0.96

0.95; 0.98

0.09

-0.09; 0.27

slight

0.96

0.95; 0.98

H02

-0.00

-0.01; 0.00

poor

0.98

0.97; 0.99

-0.00

-0.01; 0.00

poor

0.98

0.96; 0.99

-0.00

-0.00; 0.00

poor

0.99

0.9; 1.00

H03

PHDC only

             

J01

0.01

-0.05; 0.06

slight

0.58

0.53; 0.63

0.24

0.16; 0.32

fair

0.64

0.59; 0.68

0.05

-0.02; 0.12

slight

0.72

0.68; 0.77

J02

PHDC only

             

J04

0.02

-0.01; 0.06

slight

0.65

0.60; 0.70

0.07

0.02; 0.12

slight

0.66

0.61; 0.71

-0.01

-0.01; -0.00

poor

0.97

0.96; 0.98

J07

none PHDC

        

0.01

-0.01; 0.03

slight

0.54

0.48; 0.59

M01

-0.00

-0.01; 0.00

poor

0.92

0.90; 0.95

0.07

-0.03; 0.16

slight

0.86

0.82; 0.89

-0.00

-0.01; 0.00

poor

0.91

0.89; 0.94

N02

0.01

-0.03; 0.05

slight

0.58

0.53; 0.64

0.07

0.02; 0.12

slight

0.04

-0.02; 0.11

0.01

-0.01; 0.03

slight

-0.03

-0.09;0.03

N03

1.00

 

perfect

1.00

 

-0.00

-0.00; 0.00

poor

1.00

0.99; 1.00

-0.00

-0.00; 0.00

poor

1.00

0.99; 1.00

N05

none PER

   

0.40

-0.15; 0.94

fair

0.99

0.99; 1.00

     

N06

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

-0.00

-0.01; -0.00

poor

0.99

0.98; 1.00

-0.00

-0.00; 0.00

poor

0.99

0.99; 1.00

P01

0.04

-0.04; 0.13

slight

0.86

0.82; 0.89

0.12

0.03; 0.22

slight

0.80

0.77; 0.84

0.21

0.10; 0,33

fair

0.84

0.81; 0.87

P02

PHDC only

             

P03

0.13

-0.10; 0.36

slight

0.97

0.96; 0.99

0.10

-0.09; .029

slight

0.96

0.95; 0.98

-0.00

-0.01; 0.00

poor

0.98

0.97; 0.99

R01

none PER

   

-0.01

-0.00; -0.02

poor

0.91

0.89; 0.94

     

R03

0.54

0.29; 0.79

moderate

0.98

0.97; 0.99

0.21

0.04; 0.40

fair

0.93

0.90; 0.95

0.10

-0.04; 0.23

slight

0.93

0.91; 0.95

R05

self-report only

             

R06

0.09

-0.01; 0.20

slight

0.89

0.86; 0.92

0.06

-0.02; 0.14

slight

0.76

0.71; 0.80

0.04

-0.02; 0.10

slight

0.83

0.80; 0.87

S01

-0.00

-0.00;0.00

poor

0.99

0.98; 1.00

-0.00

-0.00; 0.00

poor

0.99

0.98; 1.00

-0.00

-0.00;0.0

-0.00;0.0

1.00

0.99; 1.00

S02

PHDC only

             
  1. aExcludes TCAM and ATC medication in the self-report dataset
  2. ACT Anatomical chemical therapeutic, PABAK Prevalence and bias-adjusted kappa, EDR Electronic dispensing record, TCAM Traditional, complementary, alternative medicines